Latest Metformin Stories
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news.
The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus.
A 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naive subjects with Type 2 Diabetes.
- To give a box on the ear to.